D
Bayer Aktiengesellschaft
BAYZF
$30.49
$0.29160.97%
D
Sell
11/9/2023Downgrade
Bayer Aktiengesellschaft (BAYZF) was downgraded to D from D+ on 11/9/2023 due to a major decline in the valuation index, efficiency index and volatility index. Net income declined 142.11% from -$2.05B to -$4.97B, and total capital declined 6.14% from $91.31B to $85.7B.
Bayer Aktiengesellschaft (BAYZF) was downgraded to D from D+ on 11/9/2023 due to a major decline in the valuation index, efficiency index and volatility index. Net income declined 142.11% from -$2.05B to -$4.97B, and total capital declined 6.14% from $91.31B to $85.7B.
D
Sell
9/14/2023Downgrade
Bayer Aktiengesellschaft (BAYZF) was downgraded to D+ from C- on 9/14/2023 due to a decline in the volatility index.
Bayer Aktiengesellschaft (BAYZF) was downgraded to D+ from C- on 9/14/2023 due to a decline in the volatility index.
C
Hold
8/14/2023Downgrade
Bayer Aktiengesellschaft (BAYZF) was downgraded to C- from C on 8/14/2023 due to a significant decline in the growth index, valuation index and solvency index. Earnings per share declined from $2.3775 to -$2.0907, EBIT declined 49.16% from $3.07B to $1.56B, and total revenue declined 22.1% from $15.43B to $12.02B.
Bayer Aktiengesellschaft (BAYZF) was downgraded to C- from C on 8/14/2023 due to a significant decline in the growth index, valuation index and solvency index. Earnings per share declined from $2.3775 to -$2.0907, EBIT declined 49.16% from $3.07B to $1.56B, and total revenue declined 22.1% from $15.43B to $12.02B.
C
Hold
4/10/2023Downgrade
Bayer Aktiengesellschaft (BAYZF) was downgraded to C from C+ on 4/10/2023 due to a decline in the total return index and valuation index.
Bayer Aktiengesellschaft (BAYZF) was downgraded to C from C+ on 4/10/2023 due to a decline in the total return index and valuation index.
C
Hold
3/21/2023Upgraded
Bayer Aktiengesellschaft (BAYZF) was upgraded to C+ from C on 3/21/2023 due to a noticeable increase in the growth index, volatility index and dividend index. EBIT increased 199.47% from $1.21B to $3.62B, operating cash flow increased 16.95% from $2.67B to $3.13B, and earnings per share increased from $0.56 to $0.6335.
Bayer Aktiengesellschaft (BAYZF) was upgraded to C+ from C on 3/21/2023 due to a noticeable increase in the growth index, volatility index and dividend index. EBIT increased 199.47% from $1.21B to $3.62B, operating cash flow increased 16.95% from $2.67B to $3.13B, and earnings per share increased from $0.56 to $0.6335.
C
Hold
1/31/2023Upgraded
Bayer Aktiengesellschaft (BAYZF) was upgraded to C from C- on 1/31/2023 due to a noticeable increase in the total return index, growth index and solvency index.
Bayer Aktiengesellschaft (BAYZF) was upgraded to C from C- on 1/31/2023 due to a noticeable increase in the total return index, growth index and solvency index.
C
Hold
11/11/2022Upgraded
Bayer Aktiengesellschaft (BAYZF) was upgraded to C- from D+ on 11/11/2022 due to a significant increase in the growth index, valuation index and solvency index. Earnings per share increased from -$0.3231 to $0.5596, operating cash flow increased 19.23% from $2.24B to $2.67B, and debt to equity declined from 1.16 to 1.11.
Bayer Aktiengesellschaft (BAYZF) was upgraded to C- from D+ on 11/11/2022 due to a significant increase in the growth index, valuation index and solvency index. Earnings per share increased from -$0.3231 to $0.5596, operating cash flow increased 19.23% from $2.24B to $2.67B, and debt to equity declined from 1.16 to 1.11.
D
Sell
9/8/2022Downgrade
Bayer Aktiengesellschaft (BAYZF) was downgraded to D+ from C- on 9/8/2022 due to a decline in the volatility index, total return index and solvency index.
Bayer Aktiengesellschaft (BAYZF) was downgraded to D+ from C- on 9/8/2022 due to a decline in the volatility index, total return index and solvency index.
C
Hold
8/8/2022Downgrade
Bayer Aktiengesellschaft (BAYZF) was downgraded to C- from C on 8/8/2022 due to a significant decline in the growth index, dividend index and solvency index. Earnings per share declined from $3.7563 to -$0.3231, EBIT declined 50.71% from $4.64B to $2.29B, and total revenue declined 16.82% from $16.42B to $13.65B.
Bayer Aktiengesellschaft (BAYZF) was downgraded to C- from C on 8/8/2022 due to a significant decline in the growth index, dividend index and solvency index. Earnings per share declined from $3.7563 to -$0.3231, EBIT declined 50.71% from $4.64B to $2.29B, and total revenue declined 16.82% from $16.42B to $13.65B.
C
Hold
3/15/2022Upgraded
Bayer Aktiengesellschaft (BAYZF) was upgraded to C from D+ on 3/15/2022 due to a large increase in the growth index, valuation index and dividend index. Earnings per share increased from $0.102 to $1.35, EBIT increased 966% from $624.65M to $6.66B, and total revenue increased 10.34% from $11.53B to $12.72B.
Bayer Aktiengesellschaft (BAYZF) was upgraded to C from D+ on 3/15/2022 due to a large increase in the growth index, valuation index and dividend index. Earnings per share increased from $0.102 to $1.35, EBIT increased 966% from $624.65M to $6.66B, and total revenue increased 10.34% from $11.53B to $12.72B.
D
Sell
11/10/2021Upgraded
Bayer Aktiengesellschaft (BAYZF) was upgraded to D+ from D- on 11/10/2021 due to a significant increase in the efficiency index, growth index and solvency index. Net income increased 103.56% from -$2.81B to $100.18M, earnings per share increased from -$2.8686 to $0.102, and operating cash flow increased 37.64% from $2.41B to $3.31B.
Bayer Aktiengesellschaft (BAYZF) was upgraded to D+ from D- on 11/10/2021 due to a significant increase in the efficiency index, growth index and solvency index. Net income increased 103.56% from -$2.81B to $100.18M, earnings per share increased from -$2.8686 to $0.102, and operating cash flow increased 37.64% from $2.41B to $3.31B.
D
Sell
11/8/2021Downgrade
Bayer Aktiengesellschaft (BAYZF) was downgraded to D- from D on 11/8/2021 due to a significant decline in the efficiency index, total return index and valuation index. Net income declined 211.82% from $2.52B to -$2.81B, and total capital declined 7.68% from $91.12B to $84.12B.
Bayer Aktiengesellschaft (BAYZF) was downgraded to D- from D on 11/8/2021 due to a significant decline in the efficiency index, total return index and valuation index. Net income declined 211.82% from $2.52B to -$2.81B, and total capital declined 7.68% from $91.12B to $84.12B.
D
Sell
8/5/2020Downgrade
Bayer Aktiengesellschaft (BAYZF) was downgraded to D from C on 8/5/2020 due to a significant decline in the valuation index, growth index and efficiency index. Earnings per share declined from $1.6677 to -$10.7061, net income declined 740.48% from $1.64B to -$10.52B, and EBIT declined 29.17% from $2.68B to $1.9B.
Bayer Aktiengesellschaft (BAYZF) was downgraded to D from C on 8/5/2020 due to a significant decline in the valuation index, growth index and efficiency index. Earnings per share declined from $1.6677 to -$10.7061, net income declined 740.48% from $1.64B to -$10.52B, and EBIT declined 29.17% from $2.68B to $1.9B.
C
Hold
7/27/2020Upgraded
Bayer Aktiengesellschaft (BAYZF) was upgraded to C from C- on 7/27/2020 due to an increase in the total return index, valuation index and volatility index.
Bayer Aktiengesellschaft (BAYZF) was upgraded to C from C- on 7/27/2020 due to an increase in the total return index, valuation index and volatility index.
C
Hold
6/24/2020Upgraded
Bayer Aktiengesellschaft (BAYZF) was upgraded to C- from D+ on 6/24/2020 due to an increase in the total return index and volatility index.
Bayer Aktiengesellschaft (BAYZF) was upgraded to C- from D+ on 6/24/2020 due to an increase in the total return index and volatility index.
D
Sell
6/8/2020Downgrade
Bayer Aktiengesellschaft (BAYZF) was downgraded to D+ from C- on 6/8/2020 due to a decline in the valuation index, volatility index and total return index.
Bayer Aktiengesellschaft (BAYZF) was downgraded to D+ from C- on 6/8/2020 due to a decline in the valuation index, volatility index and total return index.
C
Hold
5/21/2020Upgraded
Bayer Aktiengesellschaft (BAYZF) was upgraded to C- from D+ on 5/21/2020 due to a significant increase in the growth index, volatility index and valuation index.
Bayer Aktiengesellschaft (BAYZF) was upgraded to C- from D+ on 5/21/2020 due to a significant increase in the growth index, volatility index and valuation index.
D
Sell
5/1/2020Downgrade
Bayer Aktiengesellschaft (BAYZF) was downgraded to D+ from C- on 5/1/2020 due to a significant decline in the growth index, dividend index and total return index. Operating cash flow declined 107.03% from $3.59B to -$252.56M, and EBIT declined 22.89% from $3.48B to $2.68B.
Bayer Aktiengesellschaft (BAYZF) was downgraded to D+ from C- on 5/1/2020 due to a significant decline in the growth index, dividend index and total return index. Operating cash flow declined 107.03% from $3.59B to -$252.56M, and EBIT declined 22.89% from $3.48B to $2.68B.
C
Hold
4/9/2020Downgrade
Bayer Aktiengesellschaft (BAYZF) was downgraded to C- from C on 4/9/2020 due to a noticeable decline in the total return index and volatility index.
Bayer Aktiengesellschaft (BAYZF) was downgraded to C- from C on 4/9/2020 due to a noticeable decline in the total return index and volatility index.
C
Hold
2/28/2020Upgraded
Bayer Aktiengesellschaft (BAYZF) was upgraded to C from D+ on 2/28/2020 due to a significant increase in the valuation index, growth index and efficiency index. EBIT increased 171.96% from $1.28B to $3.48B, operating cash flow increased 41.62% from $2.54B to $3.59B, and earnings per share increased from $1.1697 to $1.593.
Bayer Aktiengesellschaft (BAYZF) was upgraded to C from D+ on 2/28/2020 due to a significant increase in the valuation index, growth index and efficiency index. EBIT increased 171.96% from $1.28B to $3.48B, operating cash flow increased 41.62% from $2.54B to $3.59B, and earnings per share increased from $1.1697 to $1.593.
D
Sell
2/27/2020Downgrade
Bayer Aktiengesellschaft (BAYZF) was downgraded to D+ from C- on 2/27/2020 due to a decline in the volatility index.
Bayer Aktiengesellschaft (BAYZF) was downgraded to D+ from C- on 2/27/2020 due to a decline in the volatility index.
C
Hold
2/4/2020Upgraded
Bayer Aktiengesellschaft (BAYZF) was upgraded to C- from D+ on 2/4/2020 due to a noticeable increase in the total return index and volatility index.
Bayer Aktiengesellschaft (BAYZF) was upgraded to C- from D+ on 2/4/2020 due to a noticeable increase in the total return index and volatility index.
D
Sell
5/1/2019Downgrade
Bayer Aktiengesellschaft (BAYZF) was downgraded to D+ from C- on 5/1/2019 due to a noticeable decline in the valuation index, dividend index and efficiency index.
Bayer Aktiengesellschaft (BAYZF) was downgraded to D+ from C- on 5/1/2019 due to a noticeable decline in the valuation index, dividend index and efficiency index.
C
Hold
3/12/2019Upgraded
Bayer Aktiengesellschaft (BAYZF) was upgraded to C- from D+ on 3/12/2019 due to an increase in the dividend index.
Bayer Aktiengesellschaft (BAYZF) was upgraded to C- from D+ on 3/12/2019 due to an increase in the dividend index.
D
Sell
10/19/2018Downgrade
Bayer Aktiengesellschaft (BAYZF) was downgraded to D+ from C- on 10/19/2018 due to a decline in the solvency index, total return index and efficiency index. Debt to equity increased from 0.37 to 1.13, net income declined 60.32% from $2.4B to $952.92M, and the quick ratio declined from 1.8 to 0.86.
Bayer Aktiengesellschaft (BAYZF) was downgraded to D+ from C- on 10/19/2018 due to a decline in the solvency index, total return index and efficiency index. Debt to equity increased from 0.37 to 1.13, net income declined 60.32% from $2.4B to $952.92M, and the quick ratio declined from 1.8 to 0.86.
C
Hold
8/17/2018Downgrade
Bayer Aktiengesellschaft (BAYZF) was downgraded to C- from C on 8/17/2018 due to a noticeable decline in the total return index, volatility index and dividend index.
Bayer Aktiengesellschaft (BAYZF) was downgraded to C- from C on 8/17/2018 due to a noticeable decline in the total return index, volatility index and dividend index.
C
Hold
3/11/2016Downgrade
Bayer AG (BAYZF) was downgraded to C from B- on 3/11/2016 due to a noticeable decline in the volatility index and total return index.
Bayer AG (BAYZF) was downgraded to C from B- on 3/11/2016 due to a noticeable decline in the volatility index and total return index.
B
Buy
2/26/2016Upgraded
Bayer AG (BAYZF) was upgraded to B- from C+ on 2/26/2016 due to an increase in the dividend index, valuation index and solvency index. Debt to equity declined from 1.01 to 0.81, and the quick ratio increased from 0.83 to 0.84.
Bayer AG (BAYZF) was upgraded to B- from C+ on 2/26/2016 due to an increase in the dividend index, valuation index and solvency index. Debt to equity declined from 1.01 to 0.81, and the quick ratio increased from 0.83 to 0.84.
C
Hold
2/8/2016Downgrade
Bayer AG (BAYZF) was downgraded to C+ from B- on 2/8/2016 due to a noticeable decline in the volatility index and solvency index.
Bayer AG (BAYZF) was downgraded to C+ from B- on 2/8/2016 due to a noticeable decline in the volatility index and solvency index.
B
Buy
1/7/2016Downgrade
Bayer AG (BAYZF) was downgraded to B- from B on 1/7/2016 due to a major decline in the total return index, volatility index and growth index. Earnings per share declined from $1.596 to $1.3434, EBIT declined 12.28% from $2.24B to $1.97B, and total revenue declined 8.29% from $13.38B to $12.27B.
Bayer AG (BAYZF) was downgraded to B- from B on 1/7/2016 due to a major decline in the total return index, volatility index and growth index. Earnings per share declined from $1.596 to $1.3434, EBIT declined 12.28% from $2.24B to $1.97B, and total revenue declined 8.29% from $13.38B to $12.27B.
B
Buy
5/1/2015Downgrade
Bayer AG (BAYZF) was downgraded to B from A- on 5/1/2015 due to a decline in the dividend index, valuation index and growth index. Operating cash flow declined 70.77% from $2.79B to $814.35M, and total revenue declined 1.17% from $13.79B to $13.63B.
Bayer AG (BAYZF) was downgraded to B from A- on 5/1/2015 due to a decline in the dividend index, valuation index and growth index. Operating cash flow declined 70.77% from $2.79B to $814.35M, and total revenue declined 1.17% from $13.79B to $13.63B.
A
Buy
3/4/2015Upgraded
Bayer AG (BAYZF) was upgraded to A- from B+ on 3/4/2015 due to an increase in the dividend index.
Bayer AG (BAYZF) was upgraded to A- from B+ on 3/4/2015 due to an increase in the dividend index.
B
Buy
2/17/2015Downgrade
Bayer AG (BAYZF) was downgraded to B+ from A- on 2/17/2015 due to a decline in the volatility index.
Bayer AG (BAYZF) was downgraded to B+ from A- on 2/17/2015 due to a decline in the volatility index.
A
Buy
1/29/2015Upgraded
Bayer AG (BAYZF) was upgraded to A- from B+ on 1/29/2015 due to an increase in the total return index and valuation index.
Bayer AG (BAYZF) was upgraded to A- from B+ on 1/29/2015 due to an increase in the total return index and valuation index.
B
Buy
12/8/2014Upgraded
Bayer AG (BAYZF) was upgraded to B+ from C on 12/8/2014 due to a significant increase in the volatility index, total return index and solvency index. The quick ratio increased from 0.9 to 1.17.
Bayer AG (BAYZF) was upgraded to B+ from C on 12/8/2014 due to a significant increase in the volatility index, total return index and solvency index. The quick ratio increased from 0.9 to 1.17.
C
Hold
9/2/2014Upgraded
Bayer AG (BAYZF) was upgraded to C from C- on 9/2/2014 due to an increase in the total return index and solvency index.
Bayer AG (BAYZF) was upgraded to C from C- on 9/2/2014 due to an increase in the total return index and solvency index.
C
Hold
8/25/2014None
Bayer Aktiengesellschaft (BAYZF) was downgraded to C- from U on 08/25/2014.
Bayer Aktiengesellschaft (BAYZF) was downgraded to C- from U on 08/25/2014.
OTC PK
05/07/2024 3:55PM Eastern
Quotes delayed
